Cypris Therapeutics Bags Over USD 500k in Pre-Seed Funding
Cypris Therapeutics has introduced a breakthrough in synthetic chemistry technology which allows development of novel chemistries for treatment of therapeutically resistant diseases, including brain and pancreatic cancers.
Cypris Therapeutics | 25/06/2024 | By Aishwarya | 226
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy